The ApoB to ApoA-1 ratio compares the total number of atherogenic particles to the main protein of HDL particles. It's computed automatically when both ApoB and ApoA-1 are measured.
This ratio is among the strongest single-value cardiovascular mortality predictors in longevity literature, outperforming traditional cholesterol ratios in large outcome studies like AMORIS and INTERHEART. A ratio under 0.7 suggests a favorable cardiovascular architecture; above 0.9 warrants aggressive intervention. When available, this ratio is often the most clinically meaningful lipid derivative.
Optimal ApoB:ApoA-1 Ratio: 0-0.7 ratio.
Typically re-tested every 12 weeks.